Novel Non-pharmacological Approaches to Heart Failure

Article

References

  1. 1.
    Mosterd, A., & Hoes, A. W. (2007). Clinical epidemiology of heart failure. Heart, 93, 1137–1146.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Stewart, S., MacIntyre, K., Hole, D. J., Capewell, S., & McMurray, J. J. (2001). More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure. European Journal of Heart Failure, 3, 315–322.PubMedCrossRefGoogle Scholar
  3. 3.
    Jhund, P. S., Macintyre, K., Simpson, C. R., Lewsey, J. D., Stewart, S., Redpath, A., Chalmers, J. W., Capewell, S., & McMurray, J. J. (2009). Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation, 119, 515–523.PubMedCrossRefGoogle Scholar
  4. 4.
    Deedwania, P. C., & Carbajal, E. (2012). Evidence-based therapy for heart failure. Medical Clinics of North America, 96, 915–931.PubMedCrossRefGoogle Scholar
  5. 5.
    Fonarow, G. C., Yancy, C. W., Hernandez, A. F., Peterson, E. D., Spertus, J. A., & Heidenreich, P. A. (2011). Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. American Heart Journal, 161, 1024–1030.PubMedCrossRefGoogle Scholar
  6. 6.
    Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., & Tracy, C. (2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death—executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death). European Heart Journal, 27, 2099–2140.PubMedCrossRefGoogle Scholar
  7. 7.
    Robbins, J. D., Maniar, P. B., Cotts, W., Parker, M. A., Bonow, R. O., & Gheorghiade, M. (2003). Prevalence and severity of mitral regurgitation in chronic systolic heart failure. American Journal of Cardiology, 91, 360–362.PubMedCrossRefGoogle Scholar
  8. 8.
    Trichon, B. H., Felker, G. M., Shaw, L. K., Cabell, C. H., & O’Connor, C. M. (2003). Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. American Journal of Cardiology, 91, 538–543.PubMedCrossRefGoogle Scholar
  9. 9.
  10. 10.
    Denti, P., Maisano, F., & Alfieri, O. (2014). Devices for mitral valve repair. Journal of Cardiovascular Translational Research. doi:10.1007/s12265-014-9543-y.
  11. 11.
    Athanasuleas, C. L., Buckberg, G. D., Stanley, A. W. H., Siler, W., Dor, V., Di Donato, M., Menicanti, L., de Oliveira, S. A., Beyersdorf, F., Kron, I. L., Suma, H., Kouchoukos, N. T., Moore, W., McCarthy, P. M., Oz, M. C., Fontan, F., Scott, M. L., Accola, K. A., & RESTORE Group. (2004). Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. Journal of the American College of Cardiology, 44, 1439–1445.PubMedCrossRefGoogle Scholar
  12. 12.
    Velazquez, E. J., Lee, K. L., Deja, M. A., Jain, A., Sopko, G., Marchenko, A., Ali, I. S., Pohost, G., Gradinac, S., Abraham, W. T., Yii, M., Prabhakaran, D., Szwed, H., Ferrazzi, P., Petrie, M. C., O’Connor, C. M., Panchavinnin, P., She, L., Bonow, R. O., Rankin, G. R., Jones, R. H., Rouleau, J. L., & Investigators, S. T. I. C. H. (2011). Coronary-artery bypass surgery in patients with left ventricular dysfunction. New England Journal of Medicine, 364, 1607–1616.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Mazzaferri, E. L., Jr., Gradinac, S., Sagic, D., Otasevic, P., Hasan, A. K., Goff, T. L., Sievert, H., Wunderlich, N., Nikolic, S. D., & Abraham, W. T. (2012). Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: results of the percutaneous ventricular restoration in chronic heart failure patients trial. American Heart Journal, 163, 812–820.PubMedCrossRefGoogle Scholar
  14. 14.
    Costa, M. A., Pencina, M., Nikolic, S., Engels, T., Templin, B., & Abraham, W. T. (2013). The PARACHUTE IV trial design and rationale: percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure and dilated left ventricles. American Heart Journal, 165, 531–536.PubMedCrossRefGoogle Scholar
  15. 15.
    Oliveira, G. H., Al-Kindi, S. G., Bezerra, H., & Costa, M. A. (2014). Left ventricular restoration devices. Journal of Cardiovascular Translational Research. doi:10.1007/s12265-014-9552-x.
  16. 16.
    Rose, E. A., Gelijns, A. C., Moskowitz, A. J., Heitjan, D. F., Stevenson, L. W., Dembitsky, W., Long, J. W., Ascheim, D. D., Tierney, A. R., Levitan, R. G., Watson, J. T., Meier, P., Ronan, N. S., Shapiro, P. A., Lazar, R. M., Miller, L. W., Gupta, L., Frazier, O. H., Desvigne-Nickens, P., Oz, M. C., Poirier, V. L., & Randomized evaluation of mechanical assistance for the treatment of congestive heart failure (REMATCH) study group. (2001). Long-term use of a left ventricular assist device for end-stage heart failure. New England Journal of Medicine, 345, 1435–1443.PubMedCrossRefGoogle Scholar
  17. 17.
    Solanki, P. (2014). Aortic counterpulsation: c-pulse and other devices for cardiac support. Journal of Cardiovascular Translational Research. doi:10.1007/s12265-014-9548-6.
  18. 18.
    Gronda, E., Lovett, E. G., Tarascio, M., Georgakopoulos, D., Grassi, G., & Vanoli, E. (2014). The baroreceptor as a therapeutic target for heart failure. Journal of Cardiovascular Translational Research. doi:10.1007/s12265-014-9546-8.
  19. 19.
    Braunwald, E., Epstein, S. E., Glick, G., Wechsler, A. S., & Braunwald, N. S. (1967). Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves. New England Journal of Medicine, 277, 1278–1283.PubMedCrossRefGoogle Scholar
  20. 20.
    De Ferrari, G. M. (2014). Vagal stimulation in heart failure. Journal of Cardiovascular Translational Research. doi:10.1007/s12265-014-9540-1.
  21. 21.
    De Ferrari, G. M., Vanoli, E., & Schwartz, P. J. (1994). Vagal activity and ventricular fibrillation. In M. N. Levy & P. J. Schwartz (Eds.), Vagal control of the heart: experimental basis and clinical implications (pp. 613–636). Armonk: Futura Publishing Co.Google Scholar
  22. 22.
    Morrow, J. I., Bingham, E., Craig, J. J., & Gray, W. J. (2000). Vagal nerve stimulation in patients with refractory epilepsy. Effect on seizure frequency, severity and quality of life. Seizure, 9, 442–445.PubMedCrossRefGoogle Scholar
  23. 23.
    Lopshire, Z. (2014). Spinal cord stimulation for heart failure: preclinical studies to determine optimal stimulation parameters for clinical efficacy. Journal of Cardiovascular Translational Research. doi:10.1007/s12265-014-9547-7.
  24. 24.
    Foreman, R. D. (2007). Neurological mechanisms of chest pain and cardiac disease. Cleveland Clinic Journal of Medicine, 74(Suppl 1), S30–S33.PubMedCrossRefGoogle Scholar
  25. 25.
    Böhm, M., Ewen, S., Linz, D., Reil, J.-C., Schirmer, S., Ukena, C., et al. (2014). Renal denervation: a novel non-pharmacological approach in heart failure. Journal of Cardiovascular Translational Research. doi:10.1007/s12265-014-9549-5.
  26. 26.
    De Ferrari, G. M., Schwartz, P. J. (2014). Left cardiac sympathetic denervation in patients with heart failure: a new indication for an old intervention? Journal of Cardiovascular Translational Research. doi:10.1007/s12265-014-9541-0.

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Division of Cardiovascular MedicineThe Ohio State UniversityColumbusUSA
  2. 2.Department of CardiologyFondazione IRCCS Policlinico San MatteoPaviaItaly
  3. 3.Cardiovascular Clinical Research CenterFondazione IRCCS Policlinico San MatteoPaviaItaly

Personalised recommendations